or metastasis to other distant organs like liver (2) . The first step in the cytolysis of the epithelial cells is the adhesion of amoebic trophozoites to the target epithelial cells (3) . Since the cytolysis of target cells is a major pathological feature of the disease, the factors contributing to the cytolysis appears to be important in understanding the amoebic disease processes. The cytopathic effects of E.
histolytica trophozoites to target cells have been attributed to toxic substances like cytotoxins (4), enterotoxins (5) , lysosomal enzymes (6) and 13 kDa and 30 kDa amoeba pore proteins (7, 8) . The proteolytic enzymes like 56 kDa major neutral protease (9), several cysteine proteinases (10) and electron-dense granules with collagenelytic activity (11) have also been suggested to be associated with the invasive (virulence) potential of the amoebic trophozoites. In addition, amoebic lectins (12, 13) , 220 kDa protein (14) , 112 kDa adhesin (15) (MoAb C8) ; e, sera from patients of amoebic liver abscess; f , sera from healthy subjects. Each set in duplicate wells stained with methylene blue was photographed. Fig. 4 . Cytopathogenicity of E. histolytica trophozoites to intestinal epithelial cell (Henle -407) monolayers: A, control epithelial cell monolayers; E. histolytica trophozoites used were; B, untreated; C, pretreated with normal peritoneal fluid (NPF); D, pretreated with monoclonal antibody (MoAb C8); E, pretreated with sera from patients of amoebic liver abscess (ALA); F, pretreated with sera from healthy subjects; G, pretreated with antiamoebic HIS. (13) (14) (15) . This may precisely be the reason for partial inhibition of adhesion/cytopathogenicity of amoebae to target cells.
The greater degree of observed inhibition in adhesion/cytopathogenicity of amoebic cells pretreated with HIS raised in mice than that of amoebic cells pretreated with pooled sera from clinical subjects suggest that HIS may contain antibodies to certain antigenic determinants of amoebae against which human host failed to mount an immune response. It is possible that combining antiamoebic antibodies raised in mice (HIS) and antiamoebic antibodies contained in the pooled serum from clinical subjects might have enhanced the degree of inhibition in adhesion/cytopathogenicity of amoebic trophozoites pretreated with such antibodies. We have earlier shown that PM associated amoebic protein of 108 and 129 kDa were recognized only by HIS. These antigens were not recognized by any of the sera from clinical subjects. All other PM-associated antigens were recognized in an identical fashion by both types of the antibodies.
It is likely, therefore, that amoebic PM proteins with molecular masses of 108 and 129 kDa may not be immunogenic in the human host. Thus, pooling these antibodies (HIS and serum of clinical subjects of amoebiasis) may not have an additive effect in practical sense in enhancing inhibition of adhesion/cytopathogenicity of the amoebae pretreated with pooled serum from clinical subjects. However, such a possibility cannot be ruled out. The data of the present investigation nevertheless bring out the fact that amoebic trophozoites mediate adhesion/cytopathogenicity by utilizing molecules like 220, 170, 112 and 29 kDa.
In addition, there may be several other unidentified molecules which may not be regularly expressed on cell surface.
Such molecules may also be involved in parasite: target cell interactions. It is thus felt that identification and characterization of cytotoxic amoebic proteins would have a way to develop effective immunogens which may induce anticolonizing and antitoxic immunity or may be useful for differentiation of pathogenic from nonpathogenic amoebic isolates from clinical subjects.
